Riskpilot← Back to searchSign inGet full accessSTANGE DYREKLINIKK AS
ASActiveOrg 923658548Postvegen 4, 2312 OttestadVeterinary activities · NACE 7500Est. 201915 employees
Revenue 2024
NOK 11,9M
-8% vs 2023
EBITDA margin
2.1%
-74% vs 2023
Equity ratio
25.0%
Financial strength
Net profit 2024
NOK 283K
-58% vs 2023
| Revenue | NOK 11,9M | -8% |
| EBITDA | NOK 252K | -74% |
| Net profit | NOK 283K | -58% |
| Total assets | NOK 2,2M | -32% |
| Equity | NOK 554K | +33% |
| Employees | 15 | — |
Legal name
STANGE DYREKLINIKK AS
Org number
923658548
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
22. oktober 2019
Share capital
NOK 30 000
Employees
15 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drive veterinærvirksomhet og annen virksomhet som står i forbindelse med dette.
Address
Postvegen 4, 2312 Ottestad
Phone
+4762572100
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 11 835 | 12 672 | 12 309 | 12 907 | 11 866 |
| Staff expenses | −4 115 | −4 998 | −5 614 | −6 152 | −5 977 |
| EBITDA | 2 489 | 2 821 | 1 671 | 966 | 252 |
| Depreciation & amort. | −58 | −52 | −52 | −51 | −57 |
| EBIT | 2 430 | 2 770 | 1 620 | 915 | 195 |
| Net financials | 1 082 | 10 | 6 | 20 | 53 |
| Profit before tax | 3 512 | 2 779 | 1 626 | 935 | 248 |
| Tax | 577 | 613 | 439 | 260 | −35 |
| Net profit | 2 935 | 2 166 | 1 187 | 675 | 283 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 698 | 4 538 | 4 170 | 3 264 | 2 218 |
| Equity | 55 | 2 221 | 666 | 418 | 554 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 643 | 2 317 | 3 504 | 2 846 | 1 665 |
| Total debt | 5 643 | 2 317 | 3 504 | 2 846 | 1 665 |
EBITDA margin
2.1%
This company
15.8%
Market median
-87% vs market
20202024
Equity ratio
25.0%
This company
38.2%
Market median
-35% vs market
20202024
Return on equity
51.2%
This company
18.4%
Market median
+178% vs market
20202024
Net profit margin
2.4%
This company
8.1%
Market median
-70% vs market
20202024
Asset turnover
5.35×
This company
1.12×
Market median
+378% vs market
20202024
Debt / equity
3.01×
This company
0.62×
Market median
-385% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
NJ Chief Executive Officer | Chief Executive Officer | 2023 |
SG Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ax Vi Vet No Holding As
STANGE DYREKLINIKK AS Board members of STANGE DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nina Jendal | Chief Executive Officer | 0 companies |
| Sølvi Gravem | Chief Executive Officer | 0 companies |
| Eirik Nilssen | Chairman | 0 companies |